杨贺 博士后
联系方式：
hyang818@suda.edu.cn
个人简介：
2015年9月至2019年7月苏州大学学士
2019年9月至2024年7月苏州大学博士
2024年7月至今苏州大学博士后
研究领域：
细胞表面改性；生物材料表面改性；人工抗原呈递细胞；肿瘤免疫治疗
主要荣誉：
2021年，第七届中国国际互联网+创新创业大赛全国铜奖，江苏省一等奖（项目负责人）
2021年，全国高分子学术论文报告会最佳墙报奖
2024年，江苏省优秀毕业生
代表性论文：
1. He Yang# , Lele Sun# , Rui Chen, Zijian Xiong, Wenzhuo Yu, Zhuang Liu*, Hong Chen*. Biomimetic Dendritic Polymeric Microspheres Induce Enhanced T Cell Activation and Expansion for Adoptive Tumor Immunotherapy. Biomaterials, 2023,296:122048.
2. He Yang, Lihua Yao, Yichen Wang, Gaojian Chen* and Hong Chen*. Advancing Cell Surface Modification in Mammalian Cells with Synthetic Molecules. Chem. Sci., 2023, 14, 13325-13345.
3. He Yang, Zijian Xiong, Xingyu Heng, Xiaomeng Niu, Yichen Wang, Lihua Yao, Lele Sun*, Zhuang Liu*, Hong Chen*. Click-Chemistry-Mediated Cell Membrane Glycopolymer Engineering to Potentiate Dendritic Cell Vaccines. Angew. Chem. Int. Ed., 2024, e202315782.
4. Xiaomeng Niu# , He Yang# , Xingyu Heng, Lihua Yao, Yichen Wang, Zhuang Liu*, Hong Chen*. Click Chemistry-Mediated Polymannose Surface-Engineered-NK cells for Immunotherapy of Triple-Negative Breast Cancer. Adv. Healthcare Mater., 2024, 2400970.
5. Heming Tang, He Yang, Wenjun Zhu, Liyan Fei, Jialei Huang, Zhuang Liu, Lei Wang*, Hong Chen*. Universal Strategy of Efficient Intracellular Macromolecule Directional Delivery Using Photothermal Pump Patch. Adv. Mater., 2023,2304365.
6. Hengyuan Zhang, Xingyu Heng, He Yang, Yu Rao, Lihua Yao, Zhichen Zhu, and Gaojian Chen*, Hong Chen*. Metal-Free Atom Transfer Radical Polymerization to Prepare Recylable Micro-Adjuvants for Dendritic Cell Vaccine. Angew. Chem. Int. Ed., 2024, e202402853.
7. Zijian Xiong, Lele Sun, He Yang, Zhisheng Xiao, Zheng Deng, Quguang Li, Chenya Wang, Fengyun Shen, Zhuang Liu*. Ni-Alginate Hydrogel Microspheres with Sustained Interleukin 2 Release to Boost Cytokine-Based Cancer Immunotherapy. Adv. Funct. Mater., 2023, 33, 2211423.
8. Lele Sun, Fengyun Shen, Zijian Xiong, He Yang, Ziliang Dong, Jian Xiang, Qingyang Gu, Qunsheng Ji, Chunhai Fan, and Zhuang Liu*. DNA Engineered Lymphocyte-Based Homologous Targeting Artificial Antigen-Presenting Cells for Personalized Cancer Immunotherapy. J. Am. Chem. Soc., 2022, 144(17), 7634-7645.